|

Ceramide NanoLiposome (Ceraxa) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Ceramide NanoLiposome

Pipeline

Phase 1: 1

Top Sponsors

  • Keystone Nano, Inc1

Indications

  • Refractory/Relapse Acute Myeloid Leukemia1
  • Acute Myeloid Leukemia, in Relapse1
  • Acute Myeloid Leukemia Refractory1
  • Cancer1

Charlottesville, Virginia1 trial

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

University of Virginia Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.